Global Flow Cytometry Market Report 2022: Rise In The Adoption Of The Flow Cytometry Approach In Academia And Research Drives Growth - ResearchAndMarkets.com

The Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, December 2, 2022
Information
Tags: 
Oncology, AIDS, Health, Research, Science, Biotechnology, Cell, HIV/AIDS, Lymph, Dendritic cell-based cancer vaccine, Lymphatic system, Safety, Component, Diagnosis, Bone marrow, Immortalised cell line, Incidence, Research, Cancer, Leukemia, Data, Prevalence, Blood, Green fluorescent protein, Flow cytometry, Tissue, AI, Lymphoma, Element, Microbiology, Immunodeficiency
Organisation: 
RESEARCH AND MARKETS
Summary
Key Points: 
  • The Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.
  • The market for flow cytometry has experienced rapid expansion as a result of the rising prevalence of chronic and infectious disorders.
  • The sample must be a single-cell suspension, which is the most important condition for effective and efficient flow cytometry analysis.
  • One of the elements anticipated to propel the flow cytometry market in the coming years is the rising prevalence of certain disorders.


The "Global Flow Cytometry Market Size, Share & Industry Trends Analysis Report By Application (Academic & Clinical and Diagnostic), By End User, By Technology (Cell Based and Bead Based), By Component, By Regional Outlook and Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.

The Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

The market is being driven by increased R&D efforts by many prominent players for the creation of multicolor assays as well as cutting-edge analytical reagents. The market for flow cytometry has experienced rapid expansion as a result of the rising prevalence of chronic and infectious disorders. Typical samples range from various cell populations isolated from tissues to a cell line producing Green Fluorescent Protein.

The sample must be a single-cell suspension, which is the most important condition for effective and efficient flow cytometry analysis. This makes sure that each cell is examined separately. Cancer and immunodeficiency are two conditions that are frequently diagnosed using flow cytometry. One of the elements anticipated to propel the flow cytometry market in the coming years is the rising prevalence of certain disorders.

Market Growth Factors

A Rise In The Adoption Of The Flow Cytometry Approach In Academia And Research

The increasing incidence and prevalence of HIV/AIDS and cancer worldwide, the growing use of flow cytometry techniques in academic and research settings, the expansion of public-private initiatives within the fields of microbiology and immuno-oncology research, technological advancements, the increasing integration of AI platforms into flow cytometry workflows, and improvements in flow cytometry software all contribute to the market's growth. During the drug research and development procedures, flow cytometry has become a crucial technique for safety as well as exploratory objectives.

A Significant Expansion In The Number Of Applications Of Flow Cytometry

There is a rise in the number of applications of flow cytometry. Immunophenotyping is the procedure that uses the cytometer the most frequently. With the use of this method, groups of cells in a dataset consisting of blood, bone marrow, or lymph can be located and measured. These cell subsets are identified by fluorescently tagging population-specific proteins on the cell surface. Immunophenotyping aids in the clinical lab diagnosis of hematological malignancies such as lymphomas and leukemia. Additionally, in cell sorting applications, a customized flow cytometer called a cell sorter may physically separate target cells into different collection tubes. Each cell is interrogated and characterized by the cytometer as it moves through the laser.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Academic & Clinical
  • Diagnostic

By End User

  • Commercial Organizations
  • Hospitals
  • Academic Institutions
  • Medical Schools & Clinical Testing Labs
  • Others

By Technology

  • Cell Based
  • Bead Based

By Component

  • Instruments
  • Reagents & Consumables
  • Software
  • Services

By Geography

Key Market Players

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Sartorius AG
  • Sysmex Corporation

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Competition Analysis - Global

Chapter 4. Global Flow Cytometry Market by Application

Chapter 5. Global Flow Cytometry Market by End User

Chapter 6. Global Flow Cytometry Market by Technology

Chapter 7. Global Flow Cytometry Market by Component

Chapter 8. Global Flow Cytometry Market by Region

Chapter 9. Company Profiles

Companies Mentioned

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Sartorius AG
  • Sysmex Corporation

For more information about this report visit https://www.researchandmarkets.com/r/mtcyw5

Copyright: 
Copyright Business Wire 2022